Surat Samachar

Cardiac Biomarkers Testing Market Is Increasing Faster to Reach $18,232 Million and Predicted to Show Highest Growth Rates by 2026

 Breaking News
  • No posts were found

Cardiac Biomarkers Testing Market Is Increasing Faster to Reach $18,232 Million and Predicted to Show Highest Growth Rates by 2026

September 05
08:16 2019
Cardiac Biomarkers Testing Market Is Increasing Faster to Reach $18,232 Million and Predicted to Show Highest Growth Rates by 2026

Cardiac Biomarkers Testing Market
North America is anticipated to continue to lead the market in the near future, owing to high awareness regarding the importance of early diagnosis of any cardiac event and favorable healthcare reimbursement policies. In addition, Asia-Pacific is expected to emerge as one of the most lucrative regions, and would closely follow Europe in terms of revenue generation.

According to a new report published by Allied Market Research, titled, Cardiac Biomarkers Testing Market by Type, Application, and Location of Testing: Global Opportunity Analysis and Industry Forecast, 2019 – 2026,”The global cardiac biomarkers testing market size generated $7,638 million in 2018, and is projected to reach $18,232 million by 2026, growing at a CAGR of 11.4% from 2019 to 2026. The cardiac troponins segment, both T and I, forefronts among all other cardiac biomarker types, holding the largest share due to its strong performance, as cardiac troponins are the most sensitive and specific biomarkers for subsequent events of myocardium injury.

Presence of large undiagnosed patient population, rise in incidence of cardiovascular diseases (CVDs), rapid urbanization, increase in disposable income, improved government funding toward healthcare, and surge in awareness about cardiac events, i.e., quick checkups after the onset of chest pain are the prime reasons responsible for the market growth in North America. Furthermore, the market growth is driven by novel progress in the treatments with improved overall survival benefits using multi-assay biomarkers. The survival benefit would be influential in governing the peak sales and market penetration of novel approved cardiac biomarker-based devices.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/5284

The global cardiac biomarkers testing market has witnessed significant growth in the past few years, and is anticipated to continue to grow at a consistent pace, due to high prevalence of cardiac diseases that widely remain undiagnosed. Large number of cardiac biomarkers in pipeline, augmented patient awareness toward the importance of early detection of cardiovascular diseases, and opportunities in untapped countries such as India, China, and other Asia-Pacific countries are the key factors that contribute toward the growth of the market. In addition, introduction of novel cardiac biomarkers for point of care (POC) testing and facilitating quick results for chronic patients serve as opportunistic approaches to drive the market growth. However, premium pricing of approved and novel single used cardiac biomarkers and uncertain government regulation regarding the approval for biomarker tests and assays are expected to hinder the market growth during the analysis period.

Based on cardiac biomarker type, the market is segmented into creatine kinase (CK-MB), troponins T and I, myoglobin, BNPs, IMA, and others. The IMA segment is expected to grow at high CAGR, as these biomarkers improve the sensitivity and negative predictive value for the diagnosis of myocardial ischemia when used in combination with standard cardiac biomarkers.

Get a purchase enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/5284

The applications covered in the study include myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. The congestive heart failure segment is expected to register the highest growth rate, owing to increased demand for biomarker tests for early detection of heart failure.

North America led the global market in 2018, due to high demand for cardiac testing, increase in prevalence rate of CVD, and rise in awareness toward cardiac diagnostics solutions. Moreover, intensive efforts taken by government and research institutes to deal with critical cardiac diseases and increase in R&D activities related to cardiac biomarkers are expected to boost the market growth in North America.

Leading market players:-

Leading market players analyzed in the research include Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Becton, Dickinson and Company, Bio-Rad Laboratories, BioMerieux, PerkinElmer Inc., Tosoh Corporation, Danaher Corporation, and Thermo Fisher Scientific.

 

Similar Reports:

Medical Bionics Market by Type, and Method of Fixation – Global Opportunity Analysis and Industry Forecast, 2017-2023

Cardiac Monitoring & Cardiac Rhythm Management Market by Product and End User – Global Opportunity Analysis and Industry Forecast, 2014-2022

 

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Media Contact
Company Name: Allied Market Research
Contact Person: David Correa
Email: Send Email
Phone: +1-800-792-5285
Address:5933 NE Win Sivers Drive #205
City: Portland
State: OR 97220
Country: United States
Website: www.alliedmarketresearch.com/cardiac-biomarkers-testing-market